Wooly Mammoth startup Colossal seeking at least $20B valuation
De-extinction firm Colossal Biosciences is reportedly targeting a valuation between $20 billion and $30 billion in a new funding round.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Colossal Biosciences, a company focused on de-extinction efforts including the wooly mammoth, is engaged in discussions to raise new capital. Reports indicate the startup is seeking a valuation of at least $20 billion, with some estimates reaching $30 billion.
Coverage from Axios, TechCrunch, Seeking Alpha, Zamin.uz, and Межа highlights these valuation targets. The outlets report on the status of these funding discussions as the company continues its operations in the biotechnology sector.
Future reports will track whether the funding round reaches the projected $20 billion to $30 billion range. Coverage does not yet specify the timeline for finalizing the deal or the identities of potential investors.
Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 4h ago.
Quick answers
What is the valuation range being sought by Colossal Biosciences?
The company is reportedly seeking a valuation between $20 billion and $30 billion.
What is the primary focus of Colossal Biosciences?
The startup is known for its de-extinction initiatives, specifically work involving the wooly mammoth.
Has the funding round been officially confirmed?
Coverage identifies the funding as currently under discussion and reports the figures as targeted goals.
Coverage (5)
- Colossal Biosciences seeks 20 to 30 billion valuation in new funding round Межа. Новини України. · 22h ago
- Colossal Biosciences, the de-extinction startup, could reach a $30 billion valuation Zamin.uz · 22h ago
- Colossal Biosciences discussing new funding at $20B or more valuation: report (IBB:NASDAQ) Seeking Alpha · 22h ago
- Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation TechCrunch · 22h ago
- Wooly Mammoth startup Colossal seeking at least $20B valuation Axios · 22h ago
Topics
Related trends
Scientists are regrowing human teeth
Researchers are developing regenerative dentistry techniques to grow human teeth, potentially replacing traditional fillings and implants.
Bristol Myers says it will build pharma's 'most powerful' AI supercomputer with Nvidia
Bristol Myers Squibb is partnering with Nvidia to construct what is being described as the life science industry's most powerful AI supercomputer.
Plants that make real dairy protein? Scientists discover an unexpected shortcut
Researchers have identified a method to produce bovine casein protein directly within plant seeds, offering a new pathway for cow-free dairy alternatives.
Databricks hits $188B valuation, extending its run as AI’s favorite second act
Data software company Databricks has secured a new funding round, reaching a valuation of $188 billion.
Ben & Jerry’s Foundation says it will shut down amid legal dispute with parent company
The Ben & Jerry’s Foundation faces potential closure following a legal dispute and reported funding cuts from its parent company.
An experimental Alzheimer's drug shows some promise as researchers hunt new approaches
Biogen’s experimental tau-targeting drug, diranersen, has triggered market volatility following the release of mixed clinical trial data.